Innovation news

Canada’s import landscape is entering a new phase as the Canada Border Services Agency’s CARM platform becomes the official system of record for all duties and taxes. By the spring of 2025, importers will manage their own digital accounts and submit financial security directly, replacing a decades‑old broker‑backed approach. For many established firms, the shift is primarily procedural. For younger ventures, however, it reshapes cash flow planning, inventory timing and compli

Canada’s next phase of artificial intelligence development is beginning to look more concrete. With new national investments in compute power planned for 2025, research teams and early-stage companies are seeing a clearer route from the lab to the marketplace. Access to high-performance GPUs and shared computing infrastructure has long been a bottleneck, particularly for small and medium-sized enterprises working in applied AI. A recently introduced AI Compute Access Fund now

Canada’s latest changes to the Scientific Research and Experimental Development (SR&ED) program are drawing attention from early‑stage founders and established research teams alike. The 2025 update raises the refundable credit ceiling and broadens eligibility for smaller firms, a shift that could bring more early projects into the national R&D ecosystem. Faster review timelines are also anticipated as automated systems begin to handle parts of the administrative process, redu

Canada’s new research security framework, set to take effect in 2025, is quietly redrawing the path from campus lab to commercial launch. The introduction of the Sensitive Technology List marks a shift in how universities, startups, and industry partners handle projects with potential geopolitical or dual‑use implications. Areas such as advanced materials, quantum computing, and biotechnology now face additional checks before collaborations proceed. Researchers who once focus

For Canadian teams developing artificial intelligence for health, 2025 brings both urgency and opportunity. Software as a Medical Device, or SaMD, now sits at the heart of how digital tools move from prototypes to regulated clinical products. The first decisive step is defining an intended use that accurately reflects the software’s medical purpose. That statement shapes classification, evidence requirements, and, ultimately, the path to regulatory authorization. Framing it t

Canada’s 2025 AI Compute Access Fund marks a timely shift in how early-stage artificial intelligence projects get off the ground. By offering subsidized GPU capacity, the program aims to help small and medium-sized enterprises handle the steep compute costs that often block research-to-market progress. Access to reliable infrastructure has become a decisive factor in whether an idea remains a prototype or becomes a functional system. The fund aligns with Canada’s broader effo

Canada’s research and development landscape is entering a new phase of adjustment. As federal plans shift toward a business‑led R&D model, the anticipated arrival of the Canada Innovation Corporation in 2026–27 signals a structural change in how early‑stage science connects with market application. This delay has left research teams and founders re‑examining their roadmaps, seeking clarity on which public programs or private pathways best fit their work while the policy frame